Santen and US ophthalmic company Eyevance enter into share purchase agreement

This article was originally published here

Since inception in 2017, Eyevance develops and commercializes topical ophthalmic products targeting the ocular surface and anterior segment. Within this area of focus, Eyevance currently offers anti-inflammatory, anti-allergic,

The post Santen and US ophthalmic company Eyevance enter into share purchase agreement appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply